Sherlock Biosciences is based in Boston. It has raised $111M in total funding. Latest round: Series B.
Sherlock Biosciences is based in Boston. Sherlock Biosciences has raised $111M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for Sherlock Biosciences runs through 2022; nothing later has been disclosed. Investors on record include Novalis LifeSciences, Illumina Ventures, Albany Capital, Catalio Capital Management, Northpond Ventures, Good Ventures. 6 distinct backers are named across the disclosed rounds.
Every Sherlock Biosciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Boston at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026